Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CG | P48736 | 8/20 | 0.35 |
| ▸ | PIK3CD | O00329 | 7/20 | 0.35 |
| ▸ | PAK4 | O96013 | 1/20 | 0.33 |
| ▸ | JAK1 | P23458 | 1/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.33 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.33 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.33 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.33 |
| ▸ | PIP4K2C | Q8TBX8 | 1/20 | 0.33 |
| ▸ | CSNK1G1 | Q9HCP0 | 1/20 | 0.33 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.30 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.30 |
| ▸ | TNIK | Q9UKE5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31507660 | 0.94 | PIK3CG (0.34) | PIK3CGPIK3CDPAK4JAK1PIK3CA | |
| SCHEMBL31507702 | 0.93 | PIK3CG (0.35) | PIK3CGPIK3CDPAK4JAK1PIK3CA | |
| SCHEMBL31507713 | 0.92 | PIK3CG (0.34) | PIK3CGPIK3CDPAK4JAK1PIK3CA | |
| SCHEMBL31507690 | 0.92 | PIK3CG (0.34) | PIK3CGPIK3CDPAK4JAK1PIK3CA | |
| SCHEMBL31507781 | 0.92 | PIK3CG (0.34) | PIK3CGPIK3CDPAK4JAK1PIK3CA | |
| SCHEMBL31507776 | 0.92 | PIK3CG (0.35) | PIK3CGPIK3CDPAK4JAK1PIK3CA | |
| SCHEMBL31507631 | 0.91 | RIPK1 (0.35) | PIK3CGPIK3CDPAK4JAK1PIK3CA | |
| SCHEMBL31507683 | 0.91 | PIK3CG (0.33) | PIK3CGPIK3CDPAK4JAK1PIK3CA | |
| SCHEMBL31507628 | 0.91 | PIK3CG (0.35) | PIK3CGPIK3CDPAK4JAK1PIK3CA | |
| SCHEMBL31507790 | 0.90 | PIK3CG (0.33) | PIK3CGPIK3CDPAK4JAK1PIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025072392-A1 | TRIAZOLOPYRIDINYL ETHER LINKED COMPOUNDS AS KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2025-04-03 | — | — | WO | disclosed |